Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 51-56

  Awazawa, Motoharu ^a,b   Ueki, Kohjiro ^a   Inabe, Kazunori ^c   Yamauchi, Toshimasa ^a   Kaneko, Kazuma ^a   Okazaki, Yukiko ^a   Bardeesy, Nabeel ^d   Ohnishi, Shin ^a   Nagai, Ryozo ^a   Kadowaki, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adipocytokine; Adiponectin; AMPK; Diabetes mellitus; Fatty acid synthesis; SREBP1c

Indexed keywords

ADENOVIRUS VECTOR; ADENYLATE KINASE; ADIPONECTIN; ADIPONECTIN RECEPTOR; CYCLOPHILIN; INSULIN; LEPTIN; LEPTIN RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE TRANSFER; HYPERINSULINEMIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; LIVER CELL; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADIPONECTIN; ANIMALS; FATTY ACIDS; HEPATOCYTES; LIVER; MICE; MICE, MUTANT STRAINS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ADIPONECTIN; RECOMBINANT PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 63149189738     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.131     Document Type: Article

References (27)

1. Matsumoto M., Ogawa W., Akimoto K., Inoue H., Miyake K., Furukawa K., Hayashi Y., Iguchi H., Matsuki Y., Hiramatsu R., Shimano H., Yamada N., Ohno S., Kasuga M., and Noda T. PKC{lambda} in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112 (2003) 935-944
2. Chen G., Liang G., Ou J., Goldstein J.L., and Brown M.S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. PNAS 101 (2004) 11245-11250
3. Taniguchi C.M., Kondo T., Sajan M., Luo J., Bronson R., Asano T., Farese R., Cantley L.C., and Kahn C.R. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKC[lambda]/[zeta]. Cell Metab. 3 (2006) 343-353
4. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., and Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 99 (1997) 846-854
5. Shimomura I., Bashmakov Y., and Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274 (1999) 30028-30032
6. Yahagi N., Shimano H., Hasty A.H., Matsuzaka T., Ide T., Yoshikawa T., Amemiya-Kudo M., Tomita S., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Osuga J.-i., Harada K., Gotoda T., Nagai R., Ishibashi S., and Yamada N. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob Mice. J. Biol. Chem. 277 (2002) 19353-19357
7. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-i., Hotta K., Shimomura I., Nakamura T., and Miyaoka K. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
8. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., and Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 (2001) 1126-1133
9. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
10. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
11. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., and Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
12. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
13. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Hara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N.H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., and Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
14. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S.L., and Cooper G.J.S. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112 (2003) 91-100
15. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., and Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10 (2004) 524-529
16. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., and Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6 (2007) 55-68
17. Shaw R.J., Lamia K.A., Vasquez D., Koo S.-H., Bardeesy N., DePinho R.A., Montminy M., and Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005) 1642-1646
18. Ueki K., Yamauchi T., Tamemoto H., Tobe K., Yamamoto-Honda R., Kaburagi Y., Akanuma Y., Yazaki Y., Aizawa S., Nagai R., and Kadowaki T. Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy. J. Clin. Invest. 105 (2000) 1437-1445
19. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., More K.J., and Breitbart R.E. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84 (1996) 491-495
20. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., and Saez E. The nuclear receptor LXR is a glucose sensor. Nature 445 (2007) 219-223
21. Tobe K., Suzuki R., Aoyama M., Yamauchi T., Kamon J., Kubota N., Terauchi Y., Matsui J., Akanuma Y., Kimura S., Tanaka J., Abe M., Ohsumi J., Nagai R., and Kadowaki T. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2-/- mouse liver. J. Biol. Chem. 276 (2001) 38337-38340
22. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., and Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297 (2002) 240-243
23. Deschatrette J., Moore E.E., Dubois M., and Weiss M.C. Dedifferentiated variants of a rat hepatoma: reversion analysis. Cell 19 (1980) 1043-1051
24. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., and Kadowaki T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13 (2007) 332-339
25. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174
26. Tsuchida A., Yamauchi T., Ito Y., Hada Y., Maki T., Takekawa S., Kamon J., Kobayashi M., Suzuki R., Hara K., Kubota N., Terauchi Y., Froguel P., Nakae J., Kasuga M., Accili D., Tobe K., Ueki K., Nagai R., and Kadowaki T. Insulin/foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279 (2004) 30817-30822
27. Shimomura I., Bashmakov Y., Ikemoto S., Horton J.D., Brown M.S., and Goldstein J.L. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. PNAS 96 (1999) 13656-13661